FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shelley Shapiro

Research Profile

Disorders

Hypertension, Pulmonary

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Activities & Behaviors

Walking

Co-author Network

Publications

TOP 3
David B Badesch; Darrin Despain; Christopher Dufton; Harrison W Farber; Jeremy Feldman; Adaani Frost; Anne Keogh; Michael A Mathier; Michael McGoon; Ronald J Oudiz; Lewis J Rubin; Shelley Shapiro; Martine Allard
ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Nazzareno Galiè; Bruce H Brundage; Hossein A Ghofrani; Ronald J Oudiz; Gerald Simonneau; Zeenat Safdar; Shelley Shapiro; R James White; Melanie Chan; Anthony Beardsworth; Lyn Frumkin; Robyn J Barst
Tadalafil therapy for pulmonary arterial hypertension.
C Shane McSwain; Raymond L Benza; Shelley Shapiro; Nicholas Hill; Robert J Schilz; C Gregory Elliott; Dianne L Zwicke; Ronald J Oudiz; James P Staszewski; Carl Arneson; Michael Wade; David Zaccardelli; Vallerie V McLaughlin
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shelley Shapiro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David B Badesch; Darrin Despain; Christopher Dufton; Harrison W Farber; Jeremy Feldman; Adaani Frost; Anne Keogh; Michael A Mathier; Michael McGoon; Ronald J Oudiz; Lewis J Rubin; Shelley Shapiro; Martine Allard
ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Cardiovascular therapeutics 2012;30(2):93-9.
2009: Nazzareno Galiè; Bruce H Brundage; Hossein A Ghofrani; Ronald J Oudiz; Gerald Simonneau; Zeenat Safdar; Shelley Shapiro; R James White; Melanie Chan; Anthony Beardsworth; Lyn Frumkin; Robyn J Barst
Tadalafil therapy for pulmonary arterial hypertension.
Circulation 2009;119(22):2894-903.
2008: C Shane McSwain; Raymond L Benza; Shelley Shapiro; Nicholas Hill; Robert J Schilz; C Gregory Elliott; Dianne L Zwicke; Ronald J Oudiz; James P Staszewski; Carl Arneson; Michael Wade; David Zaccardelli; Vallerie V McLaughlin
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
Journal of clinical pharmacology 2008;48(1):19-25.
2007: Reda E Girgis; Adaani E Frost; Nicholas S Hill; Evelyn M Horn; David Langleben; Vallerie V McLaughlin; Ronald J Oudiz; Ivan M Robbins; James R Seibold; Shelley Shapiro; Victor F Tapson; Robyn J Barst
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
Annals of the rheumatic diseases 2007;66(11):1467-72.
2006: Robyn J Barst; David Langleben; David B Badesch; Adaani Frost; E Clinton Lawrence; Shelley Shapiro; Robert Naeije; Nazzareno Galie
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Journal of the American College of Cardiology 2006;47(10):2049-56.
2005: Nazzareno Galié; David B Badesch; Ronald J Oudiz; Gérald Simonneau; Michael D McGoon; Anne M Keogh; Adaani E Frost; Diane Zwicke; Robert Naeije; Shelley Shapiro; Horst Olschewski; Lewis J Rubin
Ambrisentan therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 2005;46(3):529-35.
2005: Adaani E Frost; David Langleben; Ronald J Oudiz; Nicholas Hill; E Horn; Vallerie V McLaughlin; Ivan M Robbins; Shelley Shapiro; Victor F Tapson; Diane Zwicke; T DeMarco; Robert J Schilz; Melvyn Rubenfire; Robyn J Barst
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
Vascular pharmacology 2005;43(1):36-9.
2004: Robyn J Barst; David Langleben; Adaani Frost; Evelyn M Horn; Ronald J Oudiz; Shelley Shapiro; Vallerie V McLaughlin; Nicholas Hill; Victor F Tapson; Ivan M Robbins; Diane Zwicke; Benjamin Duncan; Richard A F Dixon; Lyn R Frumkin
Sitaxsentan therapy for pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2004;169(4):441-7.
2003: Robyn J Barst; Michael D McGoon; Vallerie V McLaughlin; Victor F Tapson; Stuart Rich; Lewis J Rubin; Karlman Wasserman; Ronald J Oudiz; Shelley Shapiro; Ivan M Robbins; Richard N Channick; David B Badesch; Barry K Rayburn; Robin Flinchbaugh; Jeff Sigman; Carl Arneson; Roger Jeffs
Beraprost therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 2003;41(12):2119-25.
2002: Marius M Hoeper; Nazzareno Galié; Srinivas Murali; Horst Olschewski; Melvyn Rubenfire; Ivan M Robbins; Harrison W Farber; Vallerie V McLaughlin; Shelley Shapiro; Joanna Pepke-Zaba; Joerg Winkler; Ralf Ewert; Christian F Opitz; Volker Westerkamp; Jean-Luc Vachiéry; Adam Torbicki; Jürgen Behr; Robyn J Barst
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2002;165(3):341-4.
2000: David B Badesch; Victor F Tapson; Michael D McGoon; B H Brundage; Lewis J Rubin; Fredrick M Wigley; Stuart Rich; Robyn J Barst; P S Barrett; K M Kral; Maria M Jöbsis; James E Loyd; S Murali; Adaani Frost; Reda E Girgis; Robert Bourge; D D Ralph; C Gregory Elliott; Nicholas S Hill; David Langleben; Robert J Schilz; Vallerie V McLaughlin; Ivan M Robbins; Bertron M Groves; Shelley Shapiro; T A Medsger
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Annals of internal medicine 2000;132(6):425-34.